Skip to Content

Formoterol / Mometasone Dosage

Applies to the following strength(s): 5 mcg-200 mcg/inh ; 5 mcg-100 mcg/inh

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Asthma - Maintenance

Two inhalations inhaled orally twice daily (morning and evening).

Each inhalation contains either 100 mcg or 200 mcg of mometasone with 5 mcg of formoterol.

Maximum Daily Dose: 800 mcg of mometasone; 20 mcg of formoterol

Comments:
-The starting dose should be determined based on patient's previous asthma therapy.
-Patients previously on inhaled medium dose corticosteroids should be started on the 100 mcg/5 mcg strength.
-Patients previously on inhaled high dose corticosteroids should be started on the 200 mcg/5 mcg strength.
-Not for use in treatment of acute bronchospasm.

Usual Pediatric Dose for Asthma - Maintenance

For children 12 years of age and older:
Two inhalations inhaled orally twice daily (morning and evening).

Each inhalation contains either 100 mcg or 200 mcg of mometasone with 5 mcg of formoterol.

Maximum Daily Dose: 800 mcg of mometasone; 20 mcg of formoterol

Comments:
-The starting dose should be determined based on patient's previous asthma therapy.
-Patients previously on inhaled medium dose corticosteroids should be started on the 100 mcg/5 mcg strength.
-Patients previously on inhaled high dose corticosteroids should be started on the 200 mcg/5 mcg strength.
-Not for use in treatment of acute bronchospasm.

Use: Indicated for patients 12 years of age and older who have inadequate control on a long-term asthma control medication or whose disease severity requires initiation of an inhaled corticosteroid and long-acting beta2-adrenergic agonist

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

US BOXED WARNING:
-The risk of asthma-related deaths is increased in patients using long-acting beta2-adrenergic agonists (LABA). This effect was observed in a clinical trial using a different LABA and is considered to be a class effect.
-Controlled clinical trial data suggest that LABA increase risk in pediatric and adolescent patients for asthma-related hospitalization.
Recommendations:
-This drug should be prescribed only for patients with inadequate asthma control currently using a long-term asthma control medication or whose disease severity requires the initiation of an inhaled corticosteroid and LABA.
-Once asthma control is achieved and maintained, reassess patient at regular intervals to determine necessity of combination inhaled corticosteroid and LABA therapy.
-Initiate step down therapy in patients no longer needing an inhaled corticosteroid and LABA combination and maintain patient on a long-term asthma control medication such as a sole inhaled corticosteroid agent.
-Avoid use of this drug in patients adequately controlled on an inhaled low or medium dose corticosteroid.

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-Rinse mouth with water without swallowing after use.
-The inhaler should be primed before using for the first time and/or if not used for more than 5 days by releasing 4 test sprays into the air, away from the face, and shaking well before each spray.
-Shake well prior to each inhalation.
-Remove the cap from the mouthpiece of the actuator before using.

Storage requirements:
-Canister should remain in actuator to ensure delivery of correct amount of medication and proper functioning of the dose counter.
-Store the 60-inhalation inhaler with mouthpiece down or in a horizontal position.

Monitoring:
-Hepatic: Monitor patients for signs of increased drug exposure.
-Immunologic: Monitor for signs of development of oral candidiasis.
-Musculoskeletal: Monitor bone mineral density (BMD) in patients at higher risk for decreased BMD.
-Musculoskeletal: Monitor growth of pediatric patients.

Hide